ArticleHealth marketing quarterly2026
Gaining market share for health: A social marketing framework for implementation science.
Article in Health marketing quarterly, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Implementation science struggles to bridge the evidence-to-practice gap because market dynamics at the T3 (translation to practice) and T4 (translation to populations) stages remain unaddressed. This commentary advances three theoretical claims: implementation stages constitute distinct markets where adoption failures are market failures; exchange theory must extend to multi-level ecosystems; and system dynamics-based interactive learning environments (SD-ILEs) enable mental model restructuring via co-created narrative experiences. I propose a social marketing framework across the T3-T4 continuum, differentiating it from leading implementation frameworks. The approach is illustrated through Pb-ROADS, a narrative-computational ILE for lead (Pb) exposure prevention. Implications include new outcome metrics (e.g., market share of evidence-based practices), practitioner competencies like "systems fluency," and a reassessment of academic training infrastructure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.